Ghana vs Namibia: Cause of death, by non-communicable diseases, ages 0-4, female
Ghana
11.4%
in 2021
Namibia
11.4%
in 2021
Ghana rank
143rd
Namibia rank
142nd
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Ghana
- Namibia
How they compare
Namibia currently reports 11.4% against 11.4% in Ghana, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Namibia ahead.
Ghana ranks 143rd and Namibia ranks 142nd of 185 countries.
Namibia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ghana | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.8% | 5.4% | 0.5% | Namibia |
| 2010s | 8.7% | 9.8% | 1.1% | Namibia |
| 2020s | 11.1% | 11.5% | 0.4% | Namibia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Ghana or Namibia?
- Namibia, at 11.4% against 11.4% in Ghana as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Ghana and Namibia?
- 0.0%, with Namibia ahead.
- How many years of comparable data are there for Ghana and Namibia?
- 6 years are reported by both, from 2000 to 2021.
- How do Ghana and Namibia rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Ghana ranks 143rd and Namibia ranks 142nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.